• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲戊氨酯,一种心脏选择性毒蕈碱拮抗剂,可刺激大鼠大脑皮层中的磷酸肌醇水解。

Methoctramine, a cardioselective muscarinic antagonist, stimulates phosphoinositide hydrolysis in rat cerebral cortex.

作者信息

Lee N H, Forray C, el-Fakahany E E

机构信息

Department of Pharmacology and Toxicology, University of Maryland School of Pharmacy, Baltimore 21201.

出版信息

Eur J Pharmacol. 1989 Aug 22;167(2):295-8. doi: 10.1016/0014-2999(89)90591-8.

DOI:10.1016/0014-2999(89)90591-8
PMID:2556288
Abstract

The cardioselective muscarinic antagonist methoctramine antagonized carbamylcholine-mediated phosphoinositide (PI) hydrolysis in a concentration-dependent fashion in dissociated rat cerebrocortical cells. However, as the concentration of methoctramine was increased above 5 microM, there was a reversal of the antagonism of the PI response. In the absence of carbamylcholine, methoctramine by itself significantly increased PI hydrolysis with a maximal effect at 30 microM. Various classes of receptor antagonists, including atropine, and ion-channel blockers were unable to block methoctramine-stimulated PI hydrolysis.

摘要

在离体大鼠大脑皮层细胞中,心脏选择性毒蕈碱拮抗剂甲戊氨酯以浓度依赖方式拮抗氨甲酰胆碱介导的磷酸肌醇(PI)水解。然而,当甲戊氨酯浓度增加至高于5微摩尔时,PI反应的拮抗作用出现逆转。在无氨甲酰胆碱的情况下,甲戊氨酯自身可显著增加PI水解,在30微摩尔时达到最大效应。包括阿托品在内的各类受体拮抗剂以及离子通道阻滞剂均无法阻断甲戊氨酯刺激的PI水解。

相似文献

1
Methoctramine, a cardioselective muscarinic antagonist, stimulates phosphoinositide hydrolysis in rat cerebral cortex.甲戊氨酯,一种心脏选择性毒蕈碱拮抗剂,可刺激大鼠大脑皮层中的磷酸肌醇水解。
Eur J Pharmacol. 1989 Aug 22;167(2):295-8. doi: 10.1016/0014-2999(89)90591-8.
2
Different mechanisms of antagonism by methoctramine of two neuronal muscarinic receptor-mediated second messenger responses.美索曲明对两种神经元毒蕈碱受体介导的第二信使反应的不同拮抗机制。
J Pharmacol Exp Ther. 1989 Dec;251(3):992-9.
3
Specificity of methoctramine in blocking muscarinic receptors which inhibit adenylate cyclase in cerebellar granule cells.
Neuropharmacology. 1990 Sep;29(9):853-60. doi: 10.1016/0028-3908(90)90160-s.
4
Characterization of the subtype of muscarinic receptor coupled to the stimulation of phosphoinositide hydrolysis in 132-1N1 human astrocytoma cells.132-1N1人星形细胞瘤细胞中与磷酸肌醇水解刺激偶联的毒蕈碱受体亚型的鉴定
Cell Mol Biol (Noisy-le-grand). 1992 Nov;38(7):701-12.
5
Presynaptic effects of methoctramine on release of acetylcholine.
Neuropharmacology. 1991 Mar;30(3):293-8. doi: 10.1016/0028-3908(91)90157-7.
6
Antimuscarinic action of methoctramine, a new cardioselective M-2 muscarinic receptor antagonist, alone and in combination with atropine and gallamine.甲溴辛托品(一种新型心脏选择性M-2毒蕈碱受体拮抗剂)单独及与阿托品和加拉明联合使用时的抗毒蕈碱作用。
Eur J Pharmacol. 1987 Dec 1;144(2):117-24. doi: 10.1016/0014-2999(87)90509-7.
7
Long-term atropine treatment lowers the efficacy of carbachol to stimulate phosphatidylinositol breakdown in the cerebral cortex and hippocampus of rats.长期使用阿托品治疗会降低卡巴胆碱刺激大鼠大脑皮层和海马体中磷脂酰肌醇分解的效果。
Biochem J. 1988 Mar 15;250(3):727-34. doi: 10.1042/bj2500727.
8
A phencyclidine recognition site is associated with N-methyl-D-aspartate inhibition of carbachol-stimulated phosphoinositide hydrolysis in rat cortical slices.
Mol Pharmacol. 1989 Jun;35(6):787-94.
9
On the involvement of multiple muscarinic receptor subtypes in the activation of phosphoinositide metabolism in rat cerebral cortex.关于多种毒蕈碱受体亚型参与大鼠大脑皮层磷酸肌醇代谢激活的研究
Mol Pharmacol. 1990 Jun;37(6):893-902.
10
Methoctramine and gallamine inhibit PI hydrolysis in guinea-pig gallbladder.
Vascul Pharmacol. 2005 Oct;43(4):242-6. doi: 10.1016/j.vph.2005.07.004. Epub 2005 Sep 19.

引用本文的文献

1
Inhibition of GTPase activity of Gi proteins and decreased agonist affinity at M2 muscarinic acetylcholine receptors by spermine and methoctramine.精胺和甲氧基氨对Gi蛋白GTP酶活性的抑制作用以及对M2毒蕈碱型乙酰胆碱受体激动剂亲和力的降低作用。
Br J Pharmacol. 1999 Jun;127(4):1021-9. doi: 10.1038/sj.bjp.0702625.